Matheis v. CSL Plasma, Inc.
This text of 346 F. Supp. 3d 723 (Matheis v. CSL Plasma, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
SYLVIA H. RAMBO, United States District Judge
This case under the Americans with Disabilities Act ("ADA"),
I. Background
The relevant facts are not in dispute. CSL is the owner and operator of a plasma donation center located in York, Pennsylvania. (Doc. 26-1, ¶ 2.) At its heart, CSL's business model consists of screening potential blood plasma donors, accepting or rejecting those potential donors, taking blood plasma from approved donors, paying those donors for their plasma, and selling the plasma to pharmaceutical manufacturing companies. (Id. at ¶¶ 5-9.) CSL is regulated by the Food and Drug Administration ("FDA") and is licensed by the Secretary of Health and Human Services. (Id. at ¶¶ 12-16.) FDA regulations guide CSL in determining whether to accept or reject potential donors and require prospective donors to undergo a physical examination and complete a medical history questionnaire. (Id. at ¶¶ 17-18.) Members of the public are allowed in CSL's reception area, but must be screened and approved before being allowed into the plasma donation portion of the facility. (Id. at ¶¶ 22-23.) CSL staff members2 obtain a blood sample and a "brief" medical history consisting of current health, surgeries, medications, diagnoses, tattoos, needle marks, and other related questions. (Id. at ¶¶ 26-27.) Staff members also perform a visual examination and may reject donors if they appear to have an undisclosed illness or if a disclosed illness appears particularly severe. (Id. at ¶¶ 28-30.) Staff use a medical reference document that lists common conditions and gives guidance on whether those conditions could cause a potential donor to be rejected. (Id. at *725¶¶ 31-32.) If the staff member is unsure whether a potential donor should be rejected, the staff member can call a licensed physician and consult about whether to accept or reject the potential donor. (Id. at ¶ 33.)
Plaintiff is a Pennsylvania citizen who has been diagnosed with post-traumatic stress disorder ("PTSD") stemming from a medical screening that occurred after a police-involved shooting. (Id. at ¶ 44.) Due to his disability, Plaintiff sometimes suffers from panic attacks when exposed to crowded or confined spaces, verbal altercations, or helicopter noise. (Id. at ¶¶ 45-46.) The symptoms associated with Plaintiff's PTSD range from physical paralysis to violent outbursts such as breaking a door off of its hinges if Plaintiff feels trapped in a confined space. (Id. at 48-49.) Despite his PTSD, Plaintiff successfully made approximately 90 plasma donations at the CSL facility between January and December 2016 and earned approximately $250-$300 per month from plasma donations. (Id. at ¶¶ 58-60.) Plaintiff never had a panic attack during the donation process. Since October 2016, Plaintiff has used a service dog, "Odin," to help him cope with his PTSD. (Id. at ¶¶ 50-51.) Odin was originally purchased as a pet and was not specifically "prescribed" by a medical professional. (Id. at ¶¶ 51-52.) Odin's training included "pressure therapy," which consisted of leaning on or lying against Plaintiff when a panic attack was imminent and "willful disobey," meaning that Odin would leave his sitting position and lead Plaintiff out of the triggering environment. (Id. at ¶¶ 54-57.)
During Odin's initial training, Plaintiff brought him to the CSL facility to allow Odin to become comfortable with places that Plaintiff frequents. (Id. at ¶ 63.) A staff member initially told Plaintiff that dogs were not allowed in the facility. (Id. at ¶ 64.) Plaintiff was instructed to confer with a staff member and informed the staff member that Odin was a service dog used to help him deal with his anxiety. (Id. at ¶¶ 65-66.) Plaintiff was informed that CSL had a policy prohibiting service animals for anxiety, but allows service animals for vision-disabled and hearing-disabled patients. (Id. at ¶¶ 40, 67-70.) According to CSL policy, this limitation is not due to health concerns related to the dog's presence. (Id. at ¶ 42.) Instead, the need for a service dog for anxiety is an indicator that the potential donor's anxiety is too severe to safely undergo the donation process. (Id. ) CSL essentially equates the use of a service dog with the need for "more than two medications daily" to treat anxiety-related issues, which is a standard reason to reject a potential donor. (Id. at ¶ 41.) This rejection criteria is based on
After Plaintiff had been rejected as a donor and informed of the CSL policy, a CSL nurse told Plaintiff that he would be able to donate if he brought a note from his physician stating that he could donate safely. (Id. at ¶¶ 70-71.) While having this conversation with the CSL nurse, Plaintiff began to have a panic attack and left the facility aided by the nurse and a general manager. (Id. at ¶¶ 74-76.) Plaintiff has not returned to CSL or any other plasma donation center since that incident. (Id. at ¶ 77.)
On May 3, 2017, Plaintiff filed a complaint alleging discrimination under the ADA, as well as either negligent infliction of emotional distress or intentional infliction *726of emotional distress under Pennsylvania law.3 (Doc. 1.) CSL filed an answer to the complaint on June 5, 2017. (Doc. 10.) After the conclusion of discovery, CSL filed the instant motion for summary judgment on March 3, 2018. (Doc. 26.) Plaintiff filed a brief in opposition on March 24, 2018, (Doc. 30,) and CLS filed a reply brief on April 15, 2018 (Doc. 32). The matter has been fully briefed and is ripe for disposition.
II. Legal Standard
Summary judgment is appropriate "if the pleadings, the discovery [including, depositions, answers to interrogatories, and admissions on file] and disclosure materials on file, and any affidavits show that there is no genuine issue as to any material fact and that the movant is entitled to judgment as a matter of law." Fed. R. Civ. P.
Free access — add to your briefcase to read the full text and ask questions with AI
SYLVIA H. RAMBO, United States District Judge
This case under the Americans with Disabilities Act ("ADA"),
I. Background
The relevant facts are not in dispute. CSL is the owner and operator of a plasma donation center located in York, Pennsylvania. (Doc. 26-1, ¶ 2.) At its heart, CSL's business model consists of screening potential blood plasma donors, accepting or rejecting those potential donors, taking blood plasma from approved donors, paying those donors for their plasma, and selling the plasma to pharmaceutical manufacturing companies. (Id. at ¶¶ 5-9.) CSL is regulated by the Food and Drug Administration ("FDA") and is licensed by the Secretary of Health and Human Services. (Id. at ¶¶ 12-16.) FDA regulations guide CSL in determining whether to accept or reject potential donors and require prospective donors to undergo a physical examination and complete a medical history questionnaire. (Id. at ¶¶ 17-18.) Members of the public are allowed in CSL's reception area, but must be screened and approved before being allowed into the plasma donation portion of the facility. (Id. at ¶¶ 22-23.) CSL staff members2 obtain a blood sample and a "brief" medical history consisting of current health, surgeries, medications, diagnoses, tattoos, needle marks, and other related questions. (Id. at ¶¶ 26-27.) Staff members also perform a visual examination and may reject donors if they appear to have an undisclosed illness or if a disclosed illness appears particularly severe. (Id. at ¶¶ 28-30.) Staff use a medical reference document that lists common conditions and gives guidance on whether those conditions could cause a potential donor to be rejected. (Id. at *725¶¶ 31-32.) If the staff member is unsure whether a potential donor should be rejected, the staff member can call a licensed physician and consult about whether to accept or reject the potential donor. (Id. at ¶ 33.)
Plaintiff is a Pennsylvania citizen who has been diagnosed with post-traumatic stress disorder ("PTSD") stemming from a medical screening that occurred after a police-involved shooting. (Id. at ¶ 44.) Due to his disability, Plaintiff sometimes suffers from panic attacks when exposed to crowded or confined spaces, verbal altercations, or helicopter noise. (Id. at ¶¶ 45-46.) The symptoms associated with Plaintiff's PTSD range from physical paralysis to violent outbursts such as breaking a door off of its hinges if Plaintiff feels trapped in a confined space. (Id. at 48-49.) Despite his PTSD, Plaintiff successfully made approximately 90 plasma donations at the CSL facility between January and December 2016 and earned approximately $250-$300 per month from plasma donations. (Id. at ¶¶ 58-60.) Plaintiff never had a panic attack during the donation process. Since October 2016, Plaintiff has used a service dog, "Odin," to help him cope with his PTSD. (Id. at ¶¶ 50-51.) Odin was originally purchased as a pet and was not specifically "prescribed" by a medical professional. (Id. at ¶¶ 51-52.) Odin's training included "pressure therapy," which consisted of leaning on or lying against Plaintiff when a panic attack was imminent and "willful disobey," meaning that Odin would leave his sitting position and lead Plaintiff out of the triggering environment. (Id. at ¶¶ 54-57.)
During Odin's initial training, Plaintiff brought him to the CSL facility to allow Odin to become comfortable with places that Plaintiff frequents. (Id. at ¶ 63.) A staff member initially told Plaintiff that dogs were not allowed in the facility. (Id. at ¶ 64.) Plaintiff was instructed to confer with a staff member and informed the staff member that Odin was a service dog used to help him deal with his anxiety. (Id. at ¶¶ 65-66.) Plaintiff was informed that CSL had a policy prohibiting service animals for anxiety, but allows service animals for vision-disabled and hearing-disabled patients. (Id. at ¶¶ 40, 67-70.) According to CSL policy, this limitation is not due to health concerns related to the dog's presence. (Id. at ¶ 42.) Instead, the need for a service dog for anxiety is an indicator that the potential donor's anxiety is too severe to safely undergo the donation process. (Id. ) CSL essentially equates the use of a service dog with the need for "more than two medications daily" to treat anxiety-related issues, which is a standard reason to reject a potential donor. (Id. at ¶ 41.) This rejection criteria is based on
After Plaintiff had been rejected as a donor and informed of the CSL policy, a CSL nurse told Plaintiff that he would be able to donate if he brought a note from his physician stating that he could donate safely. (Id. at ¶¶ 70-71.) While having this conversation with the CSL nurse, Plaintiff began to have a panic attack and left the facility aided by the nurse and a general manager. (Id. at ¶¶ 74-76.) Plaintiff has not returned to CSL or any other plasma donation center since that incident. (Id. at ¶ 77.)
On May 3, 2017, Plaintiff filed a complaint alleging discrimination under the ADA, as well as either negligent infliction of emotional distress or intentional infliction *726of emotional distress under Pennsylvania law.3 (Doc. 1.) CSL filed an answer to the complaint on June 5, 2017. (Doc. 10.) After the conclusion of discovery, CSL filed the instant motion for summary judgment on March 3, 2018. (Doc. 26.) Plaintiff filed a brief in opposition on March 24, 2018, (Doc. 30,) and CLS filed a reply brief on April 15, 2018 (Doc. 32). The matter has been fully briefed and is ripe for disposition.
II. Legal Standard
Summary judgment is appropriate "if the pleadings, the discovery [including, depositions, answers to interrogatories, and admissions on file] and disclosure materials on file, and any affidavits show that there is no genuine issue as to any material fact and that the movant is entitled to judgment as a matter of law." Fed. R. Civ. P. 56(c) ; see also Celotex Corp. v. Catrett ,
To prevail on summary judgment, the moving party must affirmatively identify those portions of the record which demonstrate the absence of a genuine issue of material fact. Celotex , 477 U.S. at 323-24,
III. Discussion
Title III of the ADA provides that individuals with disabilities must be given full and equal access to places of public accommodation and the benefits, goods, and services associated with those accommodations.
*727Sharrow v. Bailey ,
A. CSL meets the definition of public accommodation under the ADA
The ADA sets forth an enumerated list of places that qualify as a place of public accommodation:
The following private entities are considered public accommodations for purposes of this subchapter, if the operations of such entities affect commerce-
(A) an inn, hotel, motel, or other place of lodging, except for an establishment located within a building that contains not more than five rooms for rent or hire and that is actually occupied by the proprietor of such establishment as the residence of such proprietor;
(B) a restaurant, bar, or other establishment serving food or drink;
(C) a motion picture house, theater, concert hall, stadium, or other place of exhibition or entertainment;
(D) an auditorium, convention center, lecture hall, or other place of public gathering;
(E) a bakery, grocery store, clothing store, hardware store, shopping center, or other sales or rental establishment;
(F) a laundromat, dry-cleaner, bank, barber shop, beauty shop, travel service, shoe repair service, funeral parlor, gas station, office of an accountant or lawyer, pharmacy, insurance office, professional office of a health care provider, hospital, or other service establishment;
....
Not surprisingly, "plasma donation center" is not a specifically enumerated entity that is defined as a public accommodation under the ADA. Plaintiff argues that a plasma donation center qualifies as an "other service establishment" under
The Tenth Circuit Court of Appeals appears to be the only federal appellate court to have decided this issue. In Levorsen v. Octapharma Plasma, Inc. ,
The Court of Appeals began its analysis by citing two precepts a court must consider in determining whether an entity is a public accommodation under the ADA: (1) the remedial purpose of the ADA is to prohibit discrimination "on the basis of disability in the full and equal enjoyment of the goods, services, facilities, privileges, advantages, or accommodations of any place of public accommodation," and, thus, its terms must be liberally construed; and (2) the list of enumerated examples in Section 12181(7)(F) is not exhaustive; rather, they serve as mere illustrations.
Judge Holmes of the Tenth Circuit dissented, concluding that a plasma donation center was more akin to a manufacturing plant which would be excluded from the ADA's requirements. Judge Holmes, employing the canons of ejusdem generis and noscitur a sociis , determined that plasma donations centers were distinct from other enumerated service establishments in that they did not exchange a good or skilled act (e.g. shoe-repair, dry-cleaning, or accountant services) for compensation from a consumer. The dissent characterized the plasma donation centers as manufacturers, comparing them to paper mills that receive input in the form of wood and convert the wood into paper. In support of this characterization, Judge Holmes cites public health laws that define blood plasma as a "biological product" and requires that biological products be marked with the identity "of the manufacturer of the biological product." 42 U.S.C § 262(i)(1) ; 262(a)(1)(B)(ii). Furthermore, FDA regulations define "manufacturers" as any "legal person or entity engaged in the manufacture of a product subject to license under the act ...," which includes Source Plasma. See
In line with the dissent in Levorsen , the United States District Court for the Southern District of Texas in Silguero v. CSL Plasma, Inc. , No. 2:16-cv-361,
In short, this court finds the reasoning of the Tenth Circuit to be persuasive and adopts that reasoning in concluding that CSL's plasma donation center is a public accommodation under the ADA. Like the Levorsen Court, this court will begin its analysis by noting the remedial purpose of the ADA is to prohibit discrimination on the basis of disability and the court's duty to construe its terms liberally to achieve its purpose of providing equal access to disabled individuals. PGA Tour, Inc. ,
The Levorsen Court reasoned that service means "conduct or performance that assists or benefits someone or something," or "useful labor that does not produce a tangible commodity." Levorsen ,
Because this court concludes that the plain language of the statute controls, the court's inquiry need not extend further. See United States v. Locke ,
Judge Holmes also offered an alternative definition of a service establishment:
[E]very service establishment listed in [ Section] 12181(7)(F) shares some key unifying traits: they offer to the public a 'service' (1) in the form of (a) expertise (e.g. , barbers, beauticians, shoe-repair craftsman, dry cleaners, funeral parlors, lawyers, accountants, insurance offices, pharmacists, health care providers, and hospitals) or (b) specialized equipment (e.g. , laundromats and gas stations), (2) for use in achieving some desired end of the public, (3) in exchange for compensation.
Here, the first two factors are clearly met. CSL uses skilled staff and specialized equipment to screen potential donors, extract blood, and separate it into component parts. This achieves the desired end of the public in donating plasma. As discussed above, this court does not view the exchange of compensation to be dispositive; however, CSL is compensated for its effort: it is paid by the pharmaceutical companies. Thus, it would arguably satisfy the dissent's own criteria in that it receives compensation for its services.
Although the Silguero court did not look to regulatory definitions in order to determine whether a plasma donation center meets the definition of a service establishment under the ADA, Judge Holmes noted that various statutes and FDA regulations define plasma donation centers as manufacturers rather than service providers. In contrast, the Department of Justice ("DOJ") submitted an amicus curiae brief to the Tenth Circuit in Levorsen interpreting its own Technical Assistance Manual to include plasma donation centers as public accommodations. As noted by the Government in its amicus brief in Levorsen , the FDA's definition of manufacturer also includes hospitals, which are expressly included in the definition of a public accommodation. See Brief for United States Department of Justice as Amicus Curiae Supporting Appellant, Levorsen v. Octapharma Plasma Inc. ,
*733The remedial nature of the ADA requires this court to construe the definition of a public accommodation broadly to achieve the purpose of the ADA. Although a plasma donation center rests on the fringe between a service establishment and a manufacturer, the distinction becomes apparent when compared to establishments that do not provide a "service" as defined by prior case law. For example, a car manufacturing plant clearly does not fall within the bounds of Title III of the ADA because the general public is not admitted and it provides no service, or anything bearing hallmarks of a service, directly to the public. Likewise a corporate headquarters is not subject to Title III because the public would not typically be admitted and they take no action that serves individuals. In contrast, the plasma donation center is accessible to the general public and in fact encourages persons to walk in off the street to sell plasma. The donation center is far from the manufacturing plant that Defendant seeks to characterize it as. Except for separating the plasma from other blood components, the entirety of the pharmaceutical production occurs off-site and with a separate entity. Even construing the separation of blood from its component parts to be "manufacture," this process occurs after and distinct from the screening and donation process. A close analogy is a pawn shop or consignment store, although both clearly fall within a separate category of public accommodation because they have a sales aspect in addition to purchasing goods from the general public. A court would be hard-pressed to conclude that a consignment store would cease to be a public accommodation, however, simply by placing a wall between the room where clothes are bought and where they are sold. When compared to businesses clearly outside the purview of Title III, a donation center aligns more closely with a service establishment than an entity not subject to Title III. Because a plasma donation center is most similar to those types of business clearly included as service establishments and, by its conduct and performance, benefits the public by extracting plasma in exchange for a fee, this court finds that it falls within the ambit of Title III.9 Having concluded that Title III of the ADA applies, the court will next *734address whether CSL lawfully excluded Plaintiff from donating.
B. CSL had a legitimate, non-discriminatory reason for excluding Plaintiff from donating
Although this court holds that CSL must meet the requirements of Title III of the ADA, doing so does not require that CSL allow individuals with a disability to donate if that individual would endanger himself or herself, cause harm to a staff member of CSL, or cause CSL to violate FDA regulations. "The ADA does not require an entity or place of public accommodation to accommodate a person's disability by ignoring other duties imposed by law." Rose v. Springfield-Greene Cty. Health Dep't ,
Octapharma insists th[e Court's] conclusion will put [plasma donation centers] in an untenable position by creating a conflict between the ADA and certain regulations promulgated by the Food and Drug Administration. See, e.g. ,21 C.F.R. § 606.100 (b)(1) (requiring [plasma donation centers] to establish "[c]riteria used to determine donor eligibility, including acceptable medical history criteria");21 C.F.R. § 630.10 (a) (noting that [plasma donation centers] must determine donor eligibility, and that donors aren't eligible if "not in good health" or if [plasma donation center] identifies "factor(s) that may cause the donation to adversely affect" a donor's health or the "safety, purity, or potency of the blood or blood component"). We find this argument unavailing. As the United States as amicus curiae points out, the [DOJ]'s Title III regulations explicitly allow public accommodations to "impose legitimate safety requirements that are necessary for safe operation," as long as those requirements are "based on actual risks and not on mere speculation, stereotypes, or generalizations about individuals with disabilities." [ ]28 C.F.R. § 36.301 (b) ). In any event, we do not hold today that Octapharma must allow Levorsen to donate plasma. Nor do we take a position on whether Octapharma unlawfully discriminated against Levorsen under § 12182(a). We hold only that Levorsen has access to *735Octapharma as a public accommodation. Thus, we reject Octapharma's suggestion that our holding is fundamentally irreconcilable with the FDA regulations governing [plasma donation centers].
Levorsen ,
There is little in the way of guidance for when a public accommodation may deny access to a member of the public for medical reasons related to that individual's disability. Generally, in order to state a claim of discrimination under Title III of the ADA, a plaintiff must allege: "(1) that she is disabled within the meaning of the ADA; (2) that defendants own, lease or operate a place of public accommodation; and (3) that defendants discriminated against her by denying her a full and equal opportunity to enjoy the services defendants provide." Sharrow ,
A donor is ineligible to donate when donating could adversely affect the health of the donor, or when the safety, purity, or potency of the blood or blood component could be affected adversely. Your assessment of the donor must include each of the following factors:
(i) Symptoms of a recent or current illness;
(ii) Certain medical treatments or medications;
(iii) Travel to, or residence in, an area endemic for a transfusion-transmitted infection, when such screening is necessary to assure the safety, purity, and potency of blood and blood components due to the risks presented by donor travel and the risk of transmission of that transfusion-transmitted infection by such donors;
(iv) Exposure or possible exposure to an accidentally or intentionally released disease or disease agent relating to a transfusion-transmitted infection, if you know or suspect that such a release has occurred;
(v) Pregnancy at the time of, or within 6 weeks prior to, donation;
*736(vi) Whether, in the opinion of the interviewer, the donor appears to be under the influence of any drug, alcohol or for any reason does not appear to be providing reliable answers to medical history questions, or if the donor says that the purpose of donating is to obtain test results for a relevant transfusion-transmitted infection; and
(vii) The donor is a xenotransplantation product recipient.
The court does not hold that CSL will be "forced to relax its donor screening requirements, in order to satisfy the obligations of a place of public accommodation," and thus, "face revocation of its manufacturing license [from the FDA]." Francis M. Schneider, Manufacturing Public Accommodation Under Title III of the ADA: The Tenth Circuit's Expansive Interpretation of "Service Establishment" to Include Manufacturers ,
In the present case, CSL articulated a reasonable belief that Plaintiff's anxiety was so severe as to risk endangering Plaintiff's health. Dr. John Nelson, CSL's Divisional Medical Director since 2005, submitted a declaration on behalf of CSL stating that CSL had a general policy to defer potential donors who had high levels of anxiety. (Doc. 26-1, ¶¶ 36, 40-41.) This policy is based on concern that someone with high anxiety could be prone to having a panic attack while a needle is in his or her arm. (Id. at 40-41.) Although CSL uses the term "defer" to mean both temporary and permanent rejection, the instant case relates, as of now, only to a temporary denial. CSL stated that it would admit Plaintiff if he provided it with a note from a psychologist stating that he could donate safely with Odin accompanying him. (Id. at 71.) Plaintiff declined or failed to do so. (Id. at 77.) Had Plaintiff provided such a note, yet was still rejected, he may have sufficient evidence to demonstrate that CSL's legitimate basis for denial was not related to a legitimate medical concern. Plaintiff produced no such note and never attempted to donate plasma again. Thus, CSL does not argue that an outright ban of Plaintiff is necessary, merely that they must temporarily defer his donation until it can determine if his anxiety is at a level where he could safely donate. Accordingly, CSL has demonstrated a legitimate reason for temporarily rejecting Plaintiff and is entitled to summary judgment on Plaintiff's discrimination claims under the ADA. To be clear, however, the court does not hold that Plaintiff is per se ineligible to donate. Plaintiff may, in the future, demonstrate that the risk of a violent panic or anxiety attack is minimal and, thus, be eligible to donate under the FDA's safety regulations. He has yet to make such a demonstration.
IV. Conclusion
For the reasons set forth above, the court finds that CSL is a public accommodation under the ADA. Further, the court finds that Plaintiff proffered sufficient evidence to demonstrate a prima facie claim for discrimination based on his classification as disabled under the ADA; however, CSL has demonstrated a legitimate, nondiscriminatory *738basis for denying him access. Therefore, the court will grant Defendant's motion for summary judgment.
An appropriate order will issue.
Related
Cite This Page — Counsel Stack
346 F. Supp. 3d 723, Counsel Stack Legal Research, https://law.counselstack.com/opinion/matheis-v-csl-plasma-inc-pamd-2018.